Structural Genomics Centers for Infectious Diseases

What Services Does this Resource Provide?

The Structural Genomics Centers for Infectious Diseases apply state-of-the-art high-throughput technologies and methodologies to experimentally characterize the three dimensional (3-D) atomic structure of proteins or other molecules having an important biological role -in human pathogens and infectious diseases, especially those in the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases.

The Centers provide the research community with

Eligibility Criteria

Investigators in academia, not-for-profit organizations, industry, and government worldwide may request that the Centers determine the structure of proteins of interest in addition to protein targets identified by the Centers themselves.

Application Process

The process for requesting determination of protein structures is outlined on the CSGID and SSGCID websites.

Criteria for structure selection considers the properties and importance of the protein, availability of genomic or cDNA from the target organism, how determination of its structure will benefit the scientific community and inclusion on the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases.

Protein structures determined at the Centers are deposited into the Protein Data Bank (PDB), through which they are freely available to the public. The two Centers have agreed to meet certain structure completion metrics for deposition of their structures into PDB. For details on these criteria please see http://www.csgid.org/csgid/cake/pages/sg_metrics.

Assurances to Users

  • All information provided to the Centers will be treated as confidential.
  • If necessary, investigators requesting services of the Centers may negotiate a Materials Transfer Agreement to govern the exchange of research materials and tools.

Prioritization and Approval Process

Proposals for targets submitted by the community for determination of 3-D structure in addition to those identified by the Centers themselves are reviewed and approved by NIAID staff according to the following criteria:

  • Benefit to the scientific community
  • Public health importance
  • Feasibility, including, for example, physical/chemical properties of the protein for 3-D structure determination and availability of genomic or cDNA from the target organism

Highest priority is given to targets proposed by the community.

Information and Related Resources

Content last reviewed on November 10, 2016